News

Teams working to improve substance use screening in trauma centers and relieve symptoms of a connective tissue disease take home this year’s Blue Sky Awards.

A new worldwide study finds the blood thinner apixaban to be successful in reducing stroke in patients with subclinical atrial fibrillation.

MUSC neuroscientist Bashar Badran was recently recognized for his trailblazing research by the Helping to End Addiction Long-Term Initiative.

MUSC President David Cole names winners of 2023 Values in Action Awards.

MUSC is 1 of 9 leading research universities across 6 states chosen to be part of the Innosphere Ventures Regional Life Sciences Incubator.

MUSC researchers partner with Emergency Medical Services to pilot test the first MRI-equipped ambulance to speed stroke response.

The MUSC Office of Innovation is proud to announce Fabio Rizzante, D.D.S., Ph.D., as this quarter’s recipient of the I am an MUSC Innovator Award.

Three Hollings members – an M.D., a D.D.S. and a Ph.D. – are pooling their expertise to develop a personalized vaccine to prevent oral cancer from returning.

The Clinical Trialist Training Program offers early-career clinicians the time and know-how to lead clinical trials.

A new summer intern program empowers young researchers by getting them in the lab to actually help fight their own disease.